Atonarp, a manufacturer of molecular sensing and diagnostics products for the semiconductor, industrial, and life sciences industries, today announced it has raised a $50 million Series D financing, led by WRVI Capital. The new funding will allow the company to expand its operations to meet growing customer demand in its current markets and to expedite the development and commercialization of its molecular diagnostics products. The company has announced the appointment of Shaun Holt as its chief operating officer (COO).
“Atonarp is developing the future of point-of-care molecular diagnostics testing,” said Nicholas Brathwaite, founding managing partner of WRVI Capital. “As one of Atonarp’s first investors, we recognized early on that the company’s breakthrough molecular sensor technology could spur innovation across industries. With its seasoned team of technologists, Atonarp will continue to expand its first-in-class, proven and transformational molecular sensor technology platform to new industries.”